A cDNA encoding the spike (S) protein of the neurovirulent murine coronavirus JHMV variant cl-2 was isolated and sequenced. Analysis of the cDNA revealed that the S protein consists of 1376 amino acids, as does the S protein of mouse hepatitis virus 4. We inserted the cDNA into the genome of vaccinia virus to obtain a recombinant vaccinia virus (rVV). The S protein expressed in RK13 cells infected by the rVV was shown to be electrophoretically and immunologically indistinguishable from the S protein produced in DBT cells infected with cl-2 virus. RVV infection of rats and mice induced S protein-specific antibody production detectable by immunofluorescence and neutralization. Moreover, the S protein expressed by the rVV induced syncytium formation not only in mouse DBT and L cells, which are susceptible to cl-2 virus infection, but also in rabbit RK13 cells, which are not susceptible to cl-2 virus infection. This result suggests the possibility that RK13 cells have binding sites for the cl-2 virus S protein.
Introduction
Coronaviruses are enveloped positive-stranded RNA viruses associated with various diseases of humans, and domestic and experimental animals (Wege et al., 1982) . A decade of extensive molecular biological analysis has revealed that coronaviruses share an unusual replication strategy and many other common characteristics (Siddell et al., 1983; Spaan et al., 1988) .
The murine coronavirus (mouse hepatitis virus, MHV) genome of 31 kb (Spaan et al., 1988; Lee et al., 1991) encodes four major structural proteins and several nonstructural proteins. The structural proteins are the nucleocapsid (N) protein of about 50K, the membrane (M) protein of 20K to 25K, the haemaggglutininesterase (HE) protein of about 65K and the spike (S) protein of 150K to 180K (Siddell et al., 1983; Spaan et al., 1988) . In MHV-infected cells, eight discrete virusspecific mRNAs are found, and it has been shown that the N protein is translated from the smallest, mRNA7, the M protein from mRNA6, the HE protein from mRNA2-1, and the S protein from mRNA3 (Siddell et al., 1983; Spaan et al., 1988) ; the other mRNAs encode non-structural proteins (Spaan et al. 1988) .
The S protein forms the morphologically characteristic projecting spike of coronaviruses (Tyrrell et al., 1968;  The nucleotide sequence data reported in this paper have been deposited in the DDBJ, EMBL and GenBank data bases under the accession number D10255. Siddell et al., 1983) . The spike consists of dimers or trimers of the S protein proteolytically cleaved into two subunits, the N-terminal S1 and the C-terminal $2 (de Groot et al., 1987) . The S protein has important biological functions (Holmes et al., 1981; Collins et al., 1982; Sturman et al., 1985) ; it has been reported that the S protein binds to receptors on the surface of susceptible cells (Collins et al., 1982) , and it is also involved in the syncytium formation observed in MHVinfected cells (Collins et al., 1982) . This fusogenic property of the S protein has been reported to manifest only after cleavage Frana et al., 1985) . Most of the neutralizing antibodies produced in animals infected with MHV have been shown to be specific for epitopes on the S protein (Collins et al., 1982; Fleming et al., 1986; Wege et al., 1984) , and cytotoxic T cells also recognize epitopes on the S protein (Kyuwa & Stohlman, 1990) .
Another important biological function of the S protein is related to the virulence of MHV for animals. It has been clearly shown, using variant viruses which escape neutralization by S protein-specific monoclonal antibodies (MAbs), that there are epitopes on the S protein which are major determinants of virulence (Dalziel et al., 1986; Fleming et al., 1986; Wege et al., 1988) .
Studies in a number of laboratories have shown that there is considerable heterogeneity in the size of the S protein of different MHV isolates (Taguchi et al., 1985 , 0001-0654 © 1992 .SGM 1986 Morris et al., 1989; Parker et al., 1989) . We have reported that two variant viruses, cl-2 and CNSV with a larger S protein, are preferentially isolated from rat brains and cultured neural cells (Taguchi et al., 1985 (Taguchi et al., , 1986 . These animals were inoculated with a mixed virus population that consisted predominantly of virus with a smaller S protein and we believe that variants cl-2 and CNSV become the major population in rat brains because of selective growth in rat neural cells (Taguchi et al., 1985; Matsubara et al., 1991) . It has also been reported (Morris et al., 1989 ) that a virus with a smaller S protein, AT1 If cord virus, was isolated from the central nervous system of rats persistently infected with JHMV. AT1 If cord virus has a lower virulence than the virus with a larger S protein originally inoculated into the rat brains.
A detailed study recently done on variants with different size S proteins (Taguchi & Fleming, 1989) has shown that cl-2 virus, with a large S protein, is actually highly neurovirulent for rats in comparison to a virus with a small S protein, sp-4 (Matsubara et al., 1991) . All of these data suggest that the size of the S protein influences the outcome of disease. In this report, we describe the amino acid sequences deduced from the nucleotide sequences of the S protein gene of the JHMV variant cl-2, which is highly neurovirulent for rats. We also describe the properties of S protein expressed by a recombinant vaccinia virus (rVV) in cultured cells.
Methods
Virus and cells. Murine coronavirus JHMV variant cl-2 (Taguchi et al., 1985) was propagated and assayed on DBT cells as reported previously (Taguchi et al., 1980) . Wild-type (wt) VV strain WR was provided by Dr A. Kojima, National Institute of Health, Tokyo, Japan and propagated and assayed on rabbit RK13 cells. Murine L cells and RK13 cells were maintained with Dulbecco's modified MEM (DMEM) supplemented with 10% foetal calf serum (FCS).
cDNA cloning and sequencing. Total RNA from DBT cells infected with cl-2 virus was isolated using proteinase K, phenol and chloroform. Poly(A) + RNA was selected by an oligo(dT) column (Collaborative Research Incorporated). A eDNA encoding the S protein of cl-2 virus was made using the oligonucleotide 5' ACAGCAGCAATAGTAGT-CTT 3' [corresponding to the antisense sequence located at the 5' terminus of mRNA4 (Skinner & Siddell, 1985) ] as a primer. Doublestranded DNA produced according to a standard method (Maniatis et al., 1982) was inserted into the A phage genome and phages containing the S gene were selected by hybridization with 32p-labelled JHM-S1 cDNA kindly provided by Dr S. Siddell, W0rzburg, Germany. Sequencing of the cDNA was done by the dideoxynucleotide chain termination method using oligonucleotides prepared from the sequence of JHM-SI virus (Schmidt et al., 1987) . For further experiments, the cl-2 virus S cDNA was inserted into the BamHI site of pUC19 (pUC19-cl2-S) using linkers.
Construction of a transfer vector containing S protein cDNA. The transfer vector pSFB5 (Funahashi et al., 1991) was used to produce rVV. This vector has two different promoters upstream of a multiple cloning site. AIP is the promoter for the A-type inclusion body produced in cowpox virus-infected cells (Patel et al., 1988; Funahashi et al., 1988) ; 5xp7.5EBP is a promoter representing five tandemly repeated p7.5K protein promoters, which act at early times of VV infection. Tbe promoters and multiple cloning site are flanked by the haemagglutinin (HA) gene of VV (Shida, 1986) . The cl-2 virus S cDNA was excised from pUC19-cl2-S using BamHI and repaired with the Klenow fragment of DNA polymerase I to blunt the ends. The cDNA was then inserted into the SmaI site of pSFB5 to form pSFB5(cI2-S). The vector with the cl-2 virus S gene in the right orientation was identified by restriction enzyme analysis.
Production and selection ofrVV. RK13 cells prepared in 6 cm Petri dishes (Falcon) were infected with the WR strain of VV at a multiplicity of 0.1 and incubated for 1 h at 37 °C. The cells were cultured with 4 ml of DMEM supplemented with 10% FCS. Then, 5 gg of plasmid pSFB5(cI2-S) was transfected into the RK13 cells by calcium phosphate coprecipitation. After 40 to 48 h of culture, when c.p.e, was observed in more than 80% of cells, the cells were collected and disrupted by homogenization or by freezing and thawing three times. After centrifugation at 4000 r.p.m, for 10 min, the supernatant was removed and stored at -70 °C. Virus with an HA-phenotype was selected by the haemadsorption test as described previously (Shida & Matsumoto, 1983) . RVV containing the cl-2 virus S gene [rVV(cl2-S)] was selected by immunofluorescence using MAbs specific for the cl-2 virus S protein.
Growth of wt VV and r VV(cl2-S) in RK13 cells
. RK 13 cells prepared in 3 cm petri dishes (Falcon) were infected either with wt VV or rVV(cl2-S) at a multiplicity of 1. At intervals, cells were collected by scraping with a rubber policeman and disrupted by repeated freezing and thawing in dry ice and acetone. The lysates were centrifuged at 7000 r.p.m, for 5 rain, and supernatants were collected and stored at -70 °C. The virus infectivity was determined by plaque assay using RK13 cells prepared in six-well plates (Falcon) with DMEM containing 0.5% methyl cellulose. Plaques were counted 2 days after inoculation. To determine the amount of S protein expressed in RK 13 cells infected with rVV, disrupted cell pellets were solubilized with PBS pH 7.2 containing 0.65% NP40 and the supernatants, which had been clarified by centrifugation at 15000 r.p.m, for 10 min were analysed by ELISA.
Elicitation of antibodies to S protein expressed by rVV(cI2-S).
Fourweek-old BALB/c mice and Lewis rats, shown serologically to be free of MHV and related coronaviruses (CRJ, Astugi), were inoculated intraperitoneally with various doses of rVV. Four weeks later, the mice were challenged by intravenous inoculation with 106 p.f.u, rVV(cI2-S). Five weeks after the initial inoculation, mice and rats were bled and antibodies in the sera were tested by immunofluorescence, immunoprecipitation and neutralization (Taguchi et al., 1980) .
Immunoprecipitation. RK13 cells cultured in 6 cm Petri dishes (Falcon) were infected with rVV(cI2-S) at a multiplicity of 1 and labelled with [35S]methionine (100 gCi/ml; ICN, Tran35S) for 40 min at 24 h post-inoculation (p.i.). DBT cells were infected with cl-2 virus and labelled similarly at 8 to 10 h p.i. These cells were lysed in PBS containing 0.65% NP40 and were immunoprecipitated using MAbs specific for the cl-2 virus S protein, or sera from mice. The immunoprecipitates were analysed by SDS-PAGE as reported previously (Siddell et al., 1981) .
Immunofluorescence. Cells infected with rVV(cl2-S) or cl-2 virus were washed with PBS three times and fixed with acetone for 2 to 4 min. The ceils were examined for immunofluorescence using cl-2 virus S proteinspecific MAbs and fluorescein isothiocyanate-labelled anti-mouse IgG serum by standard procedures. IDLQIGNSGF LQTANYKIDT AATSCQLYYS LPKNNVTINN T K******* ********** ********** ********** ********** 501 CPTGTIHREC SLWNGPHLRS ARVGSGTYTC ECTCKPNPFD TYDLRCGQIK TIVNVGDHCE GLGVLEDKCG NSDPHKGCSC AHDSFIGWSH DTCLVNDHSQ N RC • ********* ********** ********** ********** ********** ********** ********** **~***~*** ********** *** ELISA. RKI3 cell lysates prepared after infection with wt VV or rVV(cI2-S) as described above were treated with SM-2 (Bio-Rad) for 1 h at room temperature to remove NP40. Then, the lysate was diluted five-fold with PBS and 50 ~tl of each sample was prepared in duplicate in 96-well plates (Falcon). The plates were allowed to stand overnight at 4 °C. They were treated with PBS containing 1% BSA at 37 °C for 1 h and then reacted with a mixture of four MAbs recognizing different epitopes of cl-2 virus S protein. Horseradish peroxidase-conjugated anti-mouse IgG (Bio-Yeda) diluted 1:500 was added. Secondary antibodies were detected by adding the substrate 0.005% H20: in 1 mg/ml of 5-aminosalicylic acid solution, as described previously (Yoden et aL, 1989) .
Inhibition of syncytium formation by S protein-specific MAb. Confluent
DBT cells and RK13 cell monolayers in 3 cm Petri dishes (Falcon) were infected with rVV(cl2-S) at a multiplicity of 1 and incubated at 37 °C for 1 h. Then the cells were cultured with 1 ml of DMEM supplemented with 10% FCS in the presence of cl-2 virus S protein S1 subunit-specific MAb 110-3 (unpublished data), or normal ascites fluid obtained after intraperitoneal inoculation of myeloma cells. Syncytium formation was checked microscopically for about 30 h p.i.
Results

cDNA cloning and sequence analysis
Nucleotide sequencing of the cDNA encoding the S protein of the cl-2 virus variant revealed that the open reading frame of the S gene consists of 4131 nucleotides encoding 1376 amino acids, as shown in Fig. 1 . The S protein of cl-2 virus was found to have a signal peptide, formed by a hydrophobic amino acid cluster at the N terminus and a transmembrane domain consisting of hydrophobic amino acids at the C terminus. The amino acid sequence RRARR, which is believed to be the proteolytic cleavage site, was found in the middle of the protein. There were 21 possible N-linked glycosylation sites.
Comparison of the cl-2 virus S protein with those of the JHM wb-1 (Schmidt et al., 1987; Takase-Yoden et al., 1990) and MHV-4 (Parker et al., 1989) variants showed that there is no difference in the number of amino acids composing the S proteins of the cl-2 and MHV-4 viruses (Parker et al., 1989) , but 141 amino acids were deleted from the JHM wb-1 virus S protein. There was no clustering of amino acid differences and the identity between the S proteins was more than 99%, with the exception of the deletion in the JHM wb-1 virus S protein. 
Isolation of r VV(cI2-S) and the kinetics of S protein expression in r VV( cl2-S)-infected RK13 cells
Analysis of S protein expressed in rVV(cl2-S)-infected RK13 cells
RK13 cells infected with rVV(cl2-S) and DBT cells infected with cl-2 virus were labelled with [35S]methionine and the S proteins produced in these cells were immunoprecipitated with a mixture of S protein-specific MAbs. As shown in Fig. 2(a) , a major band with an Mr of approximately 170K was detected both in RK13 cells infected with rVV(cl2-S) and in DBT cells infected with the cl-2 variant. These bands were indistinguishable by SDS-PAGE. Three other minor bands were found in the gel with approximate Mrs of 115K, 90K and 65K. The former two bands possibly correspond to the precursor S protein or the cleavage product of the S protein because they were precipitated by the S-specific MAbs. The 65K band was immunoprecipitated with normal ascites, suggesting non-specific immunoprecipitation.
Antigenicity and immunogenicity of the expressed S protein
To investigate the antigenicity of the S protein expressed in rVV(cl2-S)-infected RKI3 cells, we examined by immunofluorescence its reactivity with a panel of MAbs raised in mice by infection with the cl-2 variant. We found that 16 MAbs, which were all reactive with the authentic S protein produced in cl-2 virus-infected DBT cells, also reacted with the S protein expressed by rVV(cl2-S) in RK13 cells (data not shown). Then, we examined whether the S protein produced by rVV(cl2-S) has the ability to elicit antibody production in animals. Mice and rats were infected with rVV(cI2-S) as described in Methods and their sera were checked for S proteinspecific antibodies by immunofluorescence and neutralization. In every animal tested the presence of S proteinspecific antibodies was confirmed (Table 1) . However, the neutralization titres were low compared with the serum titre after infection of mice with cl-2 virus (data not shown). * Four week old BALB/c mice and Lewis rats were inoculated with various multiplicities of rVV(cl2-S) or wt VV intraperitoneaUy (i.p.) and/or intravenously (i.v.). Antibody titres were determined by immunofluorescence (IFA) and virus neutralization (NT) assays.
Finally we examined whether the antibodies in the serum of rVV(cl2-S)-infected animals reacted with the authentic S protein produced in cl-2 virus-infected DBT cells. DBT cell lysates prepared after infection with cl-2 virus were immunoprecipitated, a n d the precipitates were analysed by S D S -P A G E . The S protein, with an approximate Mr of 170K, was precipitated in a b u ndance, whereas trace a m o u n t s of the 115K and 90K products were precipitated by serum isolated from a mouse infected with rVV(cI2-S) (Fig. 2b) .
Expression of coronavirus JHMV S protein
Syncytium formation in rVV(cl2-S)-infected cultured cells
Since the S protein is believed to be responsible for syncytium formation in J H M V variant-infected cells, we e x a m i n e d whether the S protein produced by infection with rVV(cl2-S) also induces syncytia. T h e R K I 3 cell line, which is not susceptible to cl-2 virus infection, and DBT cells and L cells, which are susceptible to cl-2 virus infection, were examined for fusion formation after infection with rVV(cl2-S). As shown in Fig. 3, Fig. 4 and Table 2 , all the cell types tested were shown to be fused after infection with rVV(cl2-S). Syncytia were usually formed by 12 h p.i. in DBT and L cells, and by 15 to 24 h p.i. in RK13 cells after infection with rVV(cl2-S) at a multiplicity of 1 or greater. When the infected DBT and RK13 cells were incubated with medium containing a cl-2 virus S protein S1 subunit-specific MAb (110-3) at a concentration of 2 ~, syncytium formation by rVV(cl2-S) was inhibited (panels c, Fig. 3 and 4) . Normal ascites showed no influence on syncytium formation. By immunofluorescence using S protein-specific MAbs, S protein was visible in the cytoplasm of fused cells (data not shown).
Discussion
In this paper, the amino acid sequence deduced from the nucleotide sequence of the JHMV variant cl-2 S protein is reported. Also described is the expression of the S protein in cultured cells by rVV. The amino acid sequence comparison showed that the S protein of the neurovirulent cl-2 variant was 141 amino acids larger than that of the JHM wb-I variant (Schmidt et al., 1987) , which is thought to be very similar to variant sp-4 (Taguchi et al., 1986) , recently shown to be avirulent for rats (Matsubara et al., 1991) . These results suggest that the deleted domain of the S protein is involved in the neurovirulence of J H M V virus. If this is the case, it can be predicted that MHV-4, the S protein of which is 9 9~ identical to that of cl-2 virus, should be neurovirulent for rats. However, it cannot be ruled out that point mutations in regions other than the deleted 141 amino acids may also influence neurovirulence. The small difference in neurovirulence observed between the cl-2 and DL strains (Matsubara et aL, 1991) might be due to such putative point mutations, since the DL strain has been shown to have a non-deleted S protein (Banner et aL, 1990) .
It has also been shown in this paper that the S protein expressed by rVV(cl2-S) is indistinguishable in terms of molecular size, antigenicity and immunogenicity from the authentic S protein produced in DBT cells after infection with cl-2 virus. In contrast, the S protein produced in insect cells by recombinant baculovirus has been shown to be immunogenically and antigenically distinguishable from authentic S protein (Yoden et al., 1989) . These results suggest that the S protein expressed by rVV in mammalian cells is more appropriate than that expressed by recombinant baculovirus for analysis of its biological functions.
One of the important biological functions of the S protein, its fusogenic activity, could be detected in mouse cells infected with rVV(cl2-S). Interestingly, syncytium formation was also observed in RK 13 cells, which are not susceptible to MHV infection. Previously, it was thought that MHV S protein induced syncytium formation only in mouse cells (Vennema et al., 1990) ; there is a correlation between permissiveness to MHV and susceptibility to fusion by the S protein (Daya et al., 1989) .
Similarly, the S proteins of other coronaviruses expressed in cultured cells have been reported to cause syncytia only in cells of the animal species from which the virus is naturally isolated (Vennema et al., 1990; de Groot et al., 1989) . However, our results now show that this is not the case. At the moment we can not explain this discrepancy, but a number of possibilities exist. First of all, our results might be due to the virus strains used, the S protein of cl-2 virus being an exceptional case. A more likely explanation is that the amount of S protein expressed by the recombinant virus in our experiments is higher than that produced in other systems. The rVV used in our experiments has two different promoters, AIP and 5xp7.5EBP. Recombinant viruses having these promoters generally express five-to 10-fold the amount of foreign protein expressed by a conventional recombinant virus with a single 7.5K promoter (S. Funahashi et al., unpublished data) . The syncytium formation observed in RK13 cells expressing the cl-2 virus S protein suggests that there are binding sites for the S protein on the surface of the cells or, alternatively, that S protein-S protein interaction alone can lead to syncytium formation. There is no doubt that syncytia are induced by S protein expressed on the cell surface because it was inhibited by a MAb specific to the S protein of cl-2 virus. If the binding site for the cl-2 virus S protein exists on the membrane of RK13 cells, then the resistance of these cells to infection could be due to the absence of cellular factors that allow this replication. Although receptor recognition has been reported to be an important cellular determinant for resistance or susceptibility (Boyle et al., 1987) , restriction of replication after adsorption should not be disregarded. To answer these questions conclusively, it will be necessary to isolate a cDNA encoding the putative MHV receptor protein, express that in RK13 cells and determine the infectivity of MHV for these cells.
